marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-14-2024
Aileron Therapeutics Financial Ratios 2011-2024 | ALRN
Annual Financial Ratios Aileron Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-1.7 | -0.2 | -0.1 | -2.2 | -0.6 | -0.5 | -3.0 | - | - | - | - | - | - |
P/S |
- | - | - | - | - | - | - | - | - | - | - | - | - |
EPS |
-3.4 | -6.0 | -5.9 | -0.6 | -1.2 | -2.1 | -3.0 | -42.4 | -32.3 | - | - | - | - |
EV (Enterprise Value) |
17.7 M | 4.86 M | 2.87 M | 56.9 M | 22.7 M | 16 M | 61.9 M | 134 M | 100 M | - | - | - | - |
EBITDA per Share |
-3.51 | -6.05 | -5.96 | -0.52 | -1.21 | -2.15 | -3.07 | - | - | - | - | - | - |
EV/EBITDA |
-0.0 | -3.3 | -0.4 | -0.2 | -2.5 | - | - | - | - | - | - | ||
PEG |
-0.01 | -0.0 | - | -0.07 | -0.01 | -0.02 | 0.05 | - | - | - | - | - | - |
P/B |
0.3 | 0.4 | 0.0 | 4.9 | 1.1 | 0.8 | 1.4 | - | - | - | - | - | - |
P/CF |
-1.4 | -0.3 | -0.1 | -2.9 | -0.7 | -0.5 | -3.3 | - | - | - | - | - | - |
ROE % |
-228.43 | -146.75 | -59.59 | -224.71 | -183.01 | -160.95 | -47.29 | - | - | - | - | - | - |
ROA % |
-14.84 | -124.18 | -53.97 | -167.24 | -110.94 | -104.07 | -42.90 | - | - | - | - | - | - |
ROCE % |
-236.33 | -148.46 | -60.60 | -168.52 | -145.18 | -127.90 | -48.14 | - | - | - | - | - | - |
Current Ratio |
13.7 | 6.5 | 10.6 | 3.9 | 3.3 | 4.1 | 10.6 | - | - | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Aileron Therapeutics
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.27 | -0.45 | -0.86 | - | -0.4 | -0.39 | -1.05 | - | -1.4 | -1.76 | -1.86 | - | -0.07 | -0.06 | -0.08 | -0.12 | -0.13 | -0.14 | -0.24 | -0.26 | -0.28 | -0.26 | -0.49 | -0.48 | -0.5 | -0.64 | -0.52 | -0.47 | -0.45 | -10.98 | -10.58 | -10.31 | -9.84 | -12.95 | -9.25 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
- | - | -0.86 | - | - | - | -1.09 | - | -1.4 | -1.75 | -1.85 | - | -0.07 | -0.07 | -0.08 | -0.1 | -0.12 | -0.14 | -0.24 | -0.26 | -0.28 | -0.27 | -0.49 | -0.47 | -0.5 | -0.65 | -0.52 | -0.48 | -0.45 | -10.9 | -10.6 | -10.3 | -9.38 | -12.6 | -9.24 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
-16.32 | -32.63 | -46.60 | -63.77 | -91.82 | -103.57 | -117.52 | -79.31 | -92.69 | -78.01 | -60.21 | -34.87 | -75.40 | -103.32 | -129.29 | -173.42 | -177.97 | -184.96 | -193.55 | -183.01 | -173.81 | -163.45 | -167.18 | -160.95 | -139.43 | -114.60 | -76.47 | -47.29 | -28.96 | -12.08 | 3.16 | 12.70 | 8.73 | 4.95 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-35.20 | -43.84 | -48.44 | -54.88 | -78.26 | -87.40 | -98.29 | -67.97 | -80.21 | -69.07 | -54.80 | -32.42 | -62.59 | -81.09 | -98.56 | -129.07 | -126.23 | -124.76 | -124.99 | -110.94 | -106.81 | -102.06 | -106.28 | -104.07 | -93.90 | -81.25 | -59.29 | -42.90 | -50.04 | -57.34 | -73.12 | -64.47 | -44.30 | -25.13 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
-17.71 | -35.42 | -50.99 | -68.39 | -96.95 | -107.80 | -120.33 | -79.98 | -93.53 | -78.52 | -61.13 | -35.64 | -70.11 | -97.89 | -123.37 | -168.52 | -179.84 | -187.82 | -197.63 | -186.67 | -176.50 | -165.43 | -168.73 | -162.77 | -141.87 | -117.06 | -78.14 | -48.14 | -29.43 | -12.20 | 3.13 | 12.73 | 8.75 | 4.96 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
11.6 | 13.1 | 12.6 | 13.8 | 7.9 | 11.7 | 6.0 | 6.5 | 6.0 | 6.6 | 9.7 | 10.6 | 11.8 | 13.8 | 19.9 | 3.9 | 3.9 | 3.9 | 3.9 | 2.5 | 2.5 | 2.5 | 2.5 | 2.8 | 2.8 | 2.8 | 2.8 | 10.8 | 10.8 | 10.8 | 10.8 | 5.4 | 5.4 | 5.4 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency